- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.07. | Quipt Home Medical a "Top Pick" at Ventum | 1 | Cantech Letter | ||
| 04.06. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 15.05. | Quipt Home Medical Corp: Quipt Home loses $1.4-million in Q2 | 1 | Stockwatch | ||
| 15.05. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 15.05. | Quipt Home Medical GAAP EPS of -$0.03 misses by $0.04, revenue of $64M misses by $1.45M | 1 | Seeking Alpha | ||
| 15.05. | Quipt Home Medical Corp.: Quipt Home Medical Reports Second Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 10% and Adjusted EBITDA Growth of 14% | 73 | GlobeNewswire (Europe) | • Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue • Announced Normal Course Issuer Bid ("NCIB") Subsequent to Quarter End CINCINNATI, May 15, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp.... ► Artikel lesen | |
| 09.05. | Quipt Home Medical Corp: Quipt files final prospectus, amendment | 1 | Stockwatch | ||
| 09.05. | Quipt Home Medical Corp. Announces Filing of Final Base Shelf Prospectus | 1 | GlobeNewswire (USA) | ||
| 06.05. | Quipt Home Medical Corp: Quipt Home Medical to release Q2 2024 results May 15 | 1 | Stockwatch | ||
| 06.05. | Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2024 Financial Results on May 15, 2024 | 1 | GlobeNewswire (USA) | ||
| 03.05. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 02.05. | Quipt Home Medical Corp: Quipt Home to buy back up to 3.62 million shares | 2 | Stockwatch | ||
| 02.05. | Quipt Home Medical Corp.: Quipt Home Medical Announces Normal Course Issuer Bid | 136 | GlobeNewswire (Europe) | CINCINNATI, May 02, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care... ► Artikel lesen | |
| 12.04. | Quipt Home Medical Corp. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 28.03. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 28.03. | Stocks in Play: Quipt Home Medical Corp | 1 | Baystreet.ca | ||
| 28.03. | Quipt Home Medical Corp: Quipt Home shareholders elect four directors at AGM | 1 | Stockwatch | ||
| 28.03. | Quipt Home Medical Corp.: Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders | 154 | GlobeNewswire (Europe) | CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT) (TSX: QIPT)?, a U.S. based home medical equipment provider, focused on end-to-end respiratory... ► Artikel lesen | |
| 13.03. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12.03. | Quipt Home Medical Corp.: Quipt Home Medical Announces Participation in the 36th Annual Roth Investor Conference on March 17-19, 2024 | 1 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 37,180 | -1,51 % | DEUTSCHE BANK RESEARCH stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für FMC vor Quartalszahlen auf "Hold" mit einem Kursziel von 34 Euro belassen. Der Dialyseanbieter dürfte insgesamt solide Kennziffern... ► Artikel lesen | |
| VITA 34 | 4,460 | 0,00 % | Original-Research: Vita 34 AG (von Montega AG): Halten | Original-Research: Vita 34 AG - von Montega AG Einstufung von Montega AG zu Vita 34 AG Unternehmen: Vita 34 AG ISIN: DE000A0BL849 Anlass der Studie: Update Empfehlung: Halten seit: 04.06.2024... ► Artikel lesen | |
| M1 KLINIKEN | 15,350 | -2,54 % | Dividendenbekanntmachungen (18.07.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A-MARK PRECIOUS METALS INC US00181T1079 0,2 USD 0,1828 EUR ACERINOX SA ADR US00444E1038 0,1182 USD 0,1081 EUR ACUITY BRANDS INC US00508Y1029 0... ► Artikel lesen | |
| BAXTER | 32,970 | +0,79 % | Carlyle's $4B Purchase Of Baxter's Kidney Division Backed By Ares And HPS Financing | ||
| DAVITA | 129,55 | +2,37 % | What to Expect From DaVita's Q2 2024 Earnings Report | ||
| EVOFEM BIOSCIENCES | - | - | Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences | NEW DELHI (dpa-AFX) - Pharma major Lupin Ltd. announced Monday that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem Biosciences, Inc. (EVFM), a U.S. biopharmaceutical... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,060 | +2,91 % | Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results | SALT LAKE CITY, May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| EMEIS | 13,230 | +1,21 % | emeis: Half-year review (H1 2024) of the liquidity agreement entered into with Natixis ODDO BHF | Regulatory News:
Under the liquidity agreement entrusted by emeis S.A. (the "Company") (Paris:EMEIS) to Natixis ODDO BHF, the following resources were recorded in the dedicated liquidity account... ► Artikel lesen | |
| CYTOSORBENTS | 0,922 | +1,99 % | CytoSorbents Reports First Quarter 2024 Results | Product Sales up a robust 14% over prior year, and a significant 22% sequentiallyWe believe the STAR-T data presented at AATS support a favorable benefit-to-risk profile of DrugSorb-ATR in coronary... ► Artikel lesen | |
| SENSEONICS | 0,430 | +7,32 % | Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results | GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous... ► Artikel lesen | |
| NANO-X IMAGING | 8,590 | +9,29 % | Nano-X Imaging LTD.: Innovative Data Featuring Nanox AI Cardiac Solution Showcased at SCCT 2024 | ||
| UNIVERSAL HEALTH SERVICES | 194,00 | -1,52 % | Universal Health Services Lifts FY Outlook, Authorizes $1 Bln Stock Buyback; Shares Up 6% | WASHINGTON (dpa-AFX) - While reporting financial results for the second quarter on Wednesday, Universal Health Services, Inc. (UHS) increased its full-year 2024 operating results forecast and... ► Artikel lesen | |
| DELCATH SYSTEMS | 7,950 | -1,24 % | Delcath Systems Inc. Q1 Loss Beats Estimates | WASHINGTON (dpa-AFX) - Delcath Systems Inc. (DCTH) revealed Loss for first quarter that beat the Street estimates.The company's bottom line came in at -$11.11 million, or -$0.45 per share. This... ► Artikel lesen | |
| INTERPACE BIOSCIENCES | 0,990 | 0,00 % | Interpace Biosciences GAAP EPS of -$0.11 | ||
| VIROMED MEDICAL | 2,340 | +10,38 % | Viromed Medical AG: Kooperation beendet, neue Geräte in der Pipeline, Kursziel gesenkt; mwb research empfiehlt spek. KAUFEN | Die Viromed Medical AG hat die Zusammenarbeit mit der terraplasma medical GmbH beendet, die Viromed die exklusiven Vertriebsrechte in der DACH-Region für ein Kaltplasmagerät eingeräumt hatte, das fast... ► Artikel lesen |
Das Unternehmen QUIPT HOME MEDICAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,025 (+0,66 %) liegt der Kurs bei 3,785 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu QUIPT HOME MEDICAL CORP finden Sie auf Wallstreet Online.
